123 related articles for article (PubMed ID: 21485191)
1. [Preparation and antithrombogenicity of oxidated low molecular weight heparin-antithrombin complex coated-polyvinyl chloride tubing].
Luo P; Liu W; Yang C; Zhou H; Cao R; Yang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):90-4. PubMed ID: 21485191
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of open heart surgery tubing coated with heparin and lipid.
Novello WP; Santana MH; Fonseca De Arruda AC
Artif Organs; 2000 Mar; 24(3):182-4. PubMed ID: 10759636
[TBL] [Abstract][Full Text] [Related]
4. PMEA polymer-coated PVC tubing maintains anti-thrombogenic properties during in vitro whole blood circulation.
Yoshizaki T; Tabuchi N; van Oeveren W; Shibamiya A; Koyama T; Sunamori M
Int J Artif Organs; 2005 Aug; 28(8):834-40. PubMed ID: 16211534
[TBL] [Abstract][Full Text] [Related]
5. [Cytotoxicity study of heparin coated polyvinyl chloride material].
Yang J; Yi D; Liu J; Liu J; Cao R; Qin F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Aug; 22(4):739-41. PubMed ID: 16156262
[TBL] [Abstract][Full Text] [Related]
6. Coating of commercially available materials with a new heparinizable material.
Barbucci R; Albanese A; Magnani A; Tempesti F
J Biomed Mater Res; 1991 Oct; 25(10):1259-74. PubMed ID: 1839834
[TBL] [Abstract][Full Text] [Related]
7. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility.
Koromila G; Michanetzis GP; Missirlis YF; Antimisiaris SG
Biomaterials; 2006 Apr; 27(12):2525-33. PubMed ID: 16410022
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin.
Zhou Z; Meyerhoff ME
Biomaterials; 2005 Nov; 26(33):6506-17. PubMed ID: 15941584
[TBL] [Abstract][Full Text] [Related]
9. Interaction of plasma proteins with commercial protein repellent polyvinyl chloride (PVC): a word of caution.
De Somer F; Van Landschoot A; Van Nooten G; Delanghe J
Perfusion; 2008 Jul; 23(4):215-21. PubMed ID: 19181753
[TBL] [Abstract][Full Text] [Related]
10. Modified surface coatings and their effect on drug adsorption within the extracorporeal life support circuit.
Preston TJ; Ratliff TM; Gomez D; Olshove VE; Nicol KK; Sargel CL; Chicoine LG
J Extra Corpor Technol; 2010 Sep; 42(3):199-202. PubMed ID: 21114222
[TBL] [Abstract][Full Text] [Related]
11. PVC-plasticizer DEHP in medical products: do thin coatings really reduce DEHP leaching into blood?
Hildenbrand SL; Lehmann HD; Wodarz R; Ziemer G; Wendel HP
Perfusion; 2005 Oct; 20(6):351-7. PubMed ID: 16363321
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heparin microcapsule coated occluder for atrial-septal defects.
Sun Y; Wu J; Zhang RX; Shi XJ; Liu HX; Zhao Y; Yu B
Chin Med J (Engl); 2009 Jun; 122(12):1429-34. PubMed ID: 19567166
[TBL] [Abstract][Full Text] [Related]
13. The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation.
Johnell M; Larsson R; Siegbahn A
Biomaterials; 2005 May; 26(14):1731-9. PubMed ID: 15576147
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cellular morphology, adhesion, and proliferation on uncoated and differently coated PVC tubes used in extracorporeal circulation (ECC).
Moreira Pda L; Marreco PR; Moraes AM; Wada ML; Genari SC
J Biomed Mater Res B Appl Biomater; 2004 Apr; 69(1):38-45. PubMed ID: 15015208
[TBL] [Abstract][Full Text] [Related]
15. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
[TBL] [Abstract][Full Text] [Related]
16. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
17. Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent.
Lin Q; Yan J; Qiu F; Song X; Fu G; Ji J
J Biomed Mater Res A; 2011 Jan; 96(1):132-41. PubMed ID: 21105161
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
[TBL] [Abstract][Full Text] [Related]
19. Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.
Lappegård KT; Fung M; Bergseth G; Riesenfeld J; Lambris JD; Videm V; Mollnes TE
Ann Thorac Surg; 2004 Mar; 77(3):932-41. PubMed ID: 14992902
[TBL] [Abstract][Full Text] [Related]
20. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
Lavaud S; Canivet E; Wuillai A; Maheut H; Randoux C; Bonnet JM; Renaux JL; Chanard J
Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
